Skip to main content

Headlines

Esperion: FDA Approves Expanded Labels For NEXLETOL And NEXLIZET Tablets
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Idorsia: FDA Approves TRYVIO
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda : FDA Approves SNDA For Iclusig In Adult Patients With Newly Diagnosed Ph+ ALL
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
PTC Therapeutics Submits BLA To FDA For Upstaza - Quick Facts
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
FDA Approves First Gene Therapy For Kids With Early-onset MLD
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Madrigal Pharma: Rezdiffra Gets First FDA Approval For NASH
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
US FDA expands use of Bristol Myers' cancer therapy
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Geron Gets Favorable Votes From FDA Panel For Imetelstat In Treating Transfusion-Dependent Anemia
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Movano Health Says Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines In Hypoxia Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
Aprea Therapeutics' IND Application For APR-1051 Gets FDA's Nod, Shares Gain
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Mesoblast : FDA Backs Accelerated Approval For Rexlemestrocel-L In Heart Failure Patients
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
FDA Approves Expanded Indication For Novo Nordisk's Wegovy To Reduce Cardiovascular Risk
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Pulse Biosciences Gets FDA 510(k) Clearance For CellFX NsPFA Percutaneous Electrode System
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Novo Nordisk's Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets